Answers are grounded in this paper and cite their sources.
points• There is an extreme scarcity of evidence to guide cancer treatment in sub-Saharan Africa (SSA), as well as major differences between SSA and resource-rich settings regarding cancer treatment infrastructure.• A possible framework for conceptualizing cancer clinical trials in SSA is proposed, and key issues related to equipoise, innovation, and efficiency are addressed within the SSA context.• Strongly aligned cancer care and research agendas can generate forward progress for cancer treatment in the region and globally impactful clinical science that can change treatment paradigms even in resource-rich settings.
No takes yet. Share an insight, caveat, or question.
Satish Gopal (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: